Part A - Final decisions on matters referred to an expert advisory committee (November 2017)
1. Advisory Committee on Medicines Scheduling (ACMS #22)
1.8 Orphenadrine
On this page: Delegate's final decision | Public submissions on the interim decision |Interim decision | Scheduling proposal
Delegate's final decision
Final decision:
The delegate's final decision is to not to amend the scheduling of orphenadrine.
Implementation date: N/A
Reasons:
As no new evidence has been received to alter the interim decision for orphenadrine, the delegate has confirmed that the final decision and reasons for the final decision are identical to the interim decision.
Public submissions on the interim decision
No public submissions were received.
Interim decision
The interim decision for orphenadrine was published on the TGA website on 5 February 2018 at Scheduling delegates' interim decisions and invitation for further comment: ACCS/ACMS, November 2017 - 1.8. Orphenadrine.
Scheduling proposal
The pre-meeting scheduling proposal for orphenadrine was published on the TGA website on 6 September 2017 at Consultation: Proposed amendments to the Poisons Standard - ACCS, ACMS and Joint ACCS/ACMS meetings, November 2017.